Are you investing in territory realignment, a new selling model, coaching skills workshops, etc.? STOP.
Commercial leaders in the pharmaceutical and biotech industries continue to see an inconsistent return on their strategy and investments because the vast majority of first-line managers (FLMs) struggle to provide effective coaching to the skills and behaviors that drive growth.
Read this white paper about how Echelon established a quantifiable and actionable baseline of coaching quality and leveraged a three-step process for creating measurable and sustainable improvement in coaching.
